Mazyar Shadman, Deputy Chief Medical Officer (interim) and Professor of Clinical Research Division at Fred Hutch, shared a post on X about a paper he co-authored with colleagues published in Transplantation and Cellular Therapy:
“We just published our paper comparing eligibility criteria for CAR-T vs autoSCT. They are NOT the same!
Key message: Most patients are eligible for CAR-T, even with significant comorbidities.
Collaboration with other specialists is key to optimizing patients’ clinical situation.”
Title: Who Is Eligible for CAR T-Cell Therapy? Expert Perspectives on Overcoming Referral Barriers
Authors: Mazyar Shadman, Sairah Ahmed, Michael T. Byrne, Julio C. Chavez, Manali Kamdar, Mohamed L. Sorror, Miguel-Angel Perales, Joshua A. Hill, Javid Moslehi, and David B. Miklos.
You can read the Full Article in Transplantation and Cellular Therapy.
More posts featuring Mazyar Shadman.